Telomeres and telomerase in normal and malignant haematopoietic cells

European Journal of Cancer Part A

Volumn 33, Issue 5, 1997, Pages 774-780

  Norrback, K F ^a   Roos, G ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

haematopoiesis; leukaemia; lymphocyte; lymphoma; stem cell; telomerase; telomere

Indexed keywords

TELOMERASE;

ARTICLE; CELL IMMORTALIZATION; DOWN REGULATION; ENZYME ACTIVITY; HEMATOPOIESIS; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMIA; LEUKEMOGENESIS; LYMPHOCYTE PROLIFERATION; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TELOMERE;

HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA; LYMPHOMA; NEOPLASM PROTEINS; TELOMERASE; TELOMERE;

EID: 0030998216     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00059-2     Document Type: Article

References (57)

1. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994, 91, 9857-9860.
2. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995, 85, 2315-2320.
3. Slagboom PE, Droog S, Boomsma DI. Genetic determination of telomere size in humans: a twin study of three age groups. Am J Hum Genet 1994, 55, 876-882.
4. Vaziri H, Schächter F, Uchida I, et al. Loss of telomeric DNA during ageing of normal and trisomy 21 human lymphocytes. Am J Hum Genet 1993, 52, 661-667.
5. Weng NP, Levine BL, June CH, Hodes RJ. Human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc Natl Acad Sci 1995, 92, 11091-11094.
6. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990, 346, 866-868.
7. Bender MA, Preston RJ, Leonard RC, Pyatt BE, Gooch PC. Chromosomal aberration and sister-chromatid exchange frequencies in peripheral blood lymphocytes of a large human population sample. Mut Res 1989, 212, 149-154.
8. + counterparts. J Immunol 1996, 156, 3587-3590.
9. Perillo NL, Walford RL, Newman MA, Effros RB. Human T lymphocytes possess a limited in vitro life span. Exp Geronrol 1988, 24, 177-187.
10. + T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence. Exp Gerontol 1994, 29, 601-609.
11. + cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 1996, 10, F17-F22.
12. Lange de T, Shiue L, Myers RM, et al. Structure and variability of human chromosome ends. Mol Cell Biol 1990, 10, 518-527.
13. Sandell LL, Zakian VA. Loss of a yeast telomere: arrest, recovery, and chromosome loss. Cell 1993, 75, 729-739.
14. Lansdorp PM, Verwoerd NP, van de Rijke FM, et al. Heterogeneity in telomere length of human chromosomes. Human Mol Genet 1996, 5, 685-691.
15. Chiu C-P, Dragowska W, Kim NW, et al. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 1996, 14, 239-248.
16. Norrback K-F, Dahlenborg K, Carlsson R, Roos G. Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas. Blood 1996, 88, 222-229.
17. Broccoli D, Young JW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995, 92, 9082-9086.
18. Hiyama K, Hirai Y, Kyoizumi S, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995, 155, 3712-3715.
19. Weng N-P, Levine BL, June CH, Hodes RJ. Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 1996, 183, 2471-2479.
20. Igarashi H, Sakaguchi N. Telomerase activity is induced by the stimulation to antigen receptor in human peripheral lymphocytes. Biochem Biophys Res Comm 1996, 219, 649-655.
21. Buchkovich KJ, Greider CW. Telomerase regulation during entry into the cell cycle in normal human T cells. Mol Biol Cell 1996, 7, 1443-1454.
22. Holt SE, Wright WE, Shay JW. Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 1996, 16, 2932-2939.
23. Sharma HW, Sokoloski JA, Perez JR, et al. Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sci USA 1995, 92, 12343-12346.
24. Albanell J, Han W, Mellado B, et al. Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumour cell lines. Cancer Res 1996, 56, 1503-1508.
25. Xu D, Gruber A, Peterson C, Pisa P. Suppression of telomerase activity in HL60 cells after treatment with differentiating agents. Leukemia 1996, 10, 1354-1357.
26. Bestilny LJ, Brown CB, Miura Y, Robertson LD, Riabowol KT. Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines. Cancer Res 1996, 56, 3796-3802.
27. Counter CM, Botelho FM, Wang P, Harley CB, Baccetti S. Stabilization of short telomeres and telomerase activity accompany immortalisation of Epstein-Barr virus-transformed human B lymphocytes. J Virol 1994, 68, 3410-3414.
28. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW. Human telomerase RNA and telomerase activity in immortal cell lines and tumour tissues. Cancer Res 1996, 56, 645-650.
29. Ugazio AG, Maccario R, Notarangelo LD, Burgio GR. Immunology of Down's syndrome: a review. Am J Med Genet Supp 1990, 7, 204-212.
30. Rabinowe SL, Rubin IL, George KL, Adri MNS, Eisenbarth GS. Trisomy 21 (Down's syndrome): autoimmunity, ageing and monoclonal antibody-defined T-cell abnormalities. Autoimmun 1989, 2, 25-30.
31. Taylor AMR, Oxford JM, Metcalfe JA. Spontaneous cytogenetic abnormalities in lymphocytes from thirteen patients with ataxia telangiectasia. Int J Cancer 1981, 27, 311-319.
32. Kojis TL, Gatti RA, Sparkes RS. The cytogenetics of ataxia telangiectasia. Cancer Genet Cytogenet 1991, 56, 143-156.
33. Metcalfe JA, Parkhill J, Campbell L, et al. Accelerated telomere shortening in ataxia telangiectasia. Nature Genet 1996, 13, 350-353.
34. Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992, 89, 10114-10118.
35. Schulz VP, Zakian VA, Osburn CE, et al. Accelerated loss of telomeric repeats may not explain accelerated replicative decline of Werner syndrome cells. Hum Genet 1996, 97, 750-754.
36. Ohyashiki K, Ohyashiki JH, Iwama H, Hayashi S, Shay JW, Toyama K. Telomerase reactivation in leukemia cells. Int J Oncol 1996, 8, 417-421.
37. Temperani P, Giacobbi F, Gandini G, Torelli U, Emilia G. Chromosome rearrangements at telomeric level in hematologic disorders. Cancer Genet Cytogenet 1995, 83, 121-126.
38. Fitzgerald PH, Morris CM. Telomeric association of chromosomes in B-cell lymphoid leukemia. Hum Genet 1984, 67, 385-390.
39. Morgan R, Jarzabek V, Jaffe JP, Hecht K, Hecht F, Sandberg AA. Telomeric fusion in pre-T-cell acute lymphoblastic leukemia. Hum Genet 1986, 73, 260-263.
40. Saltman D, Ross FM, Fantes JA, Allshire R, Turner GE, Evans HJ. Telomeric associations in a lymphoblastoid cell line from a patient with B-cell follicular lymphoma. Cytogenet Cell Genet 1989, 50, 230-233.
41. Counter CM, Avilion AA, Le Feuvre CE, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992, 11, 1921-1929.
42. Ohyashiki K, Ohyashiki JH, Fujimura T. Telomere shortening in leukemic cells is related to their genetic alterations but not replicative capability. Cancer Genet Cytogenet 1994, 78, 64-67.
43. Yamada O, Oshimi K, Motoji T, Mizoguchi H. Telomeric DNA in normal and leukemic blood cells. J Clin Invest 1994, 95, 1117-1123.
44. Adamson DJA, King DJ, Haites NE. Significant telomere shortening in childhood leukemia. Cancer Genet Cytogenet 1992, 61, 204-206.
45. Nilsson P, Mehle C, Remes K, Roos G. Telomerase activity in vivo in human malignant hematopoietic cells. Oncogene 1994, 9, 3043-3048.
46. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266, 2011-2015.
47. Ohyashiki JH, Ohyashiki K, Fujimura T, et al. Telomere shortening associated with disease evolution patterns in myelodys-plastic syndromes. Cancer Res 1994, 54, 3557-3560.
48. Zhang W, Piatyszek MA, Kobayashi T, et al. Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents. Clin Cancer Res 1996, 2, 799-803.
49. Greaves M. Is telomerase activity in cancer due to selection of stem cells and differentiation arrest? Trends Genet 1996, 12, 127-128.
50. Shay JW, Wright WE. The reactivation of telomerase activity in cancer progression. Trends Genet 1996, 12, 129-130.
51. Holt SE, Shay JW, Wright WE. Refining the telomere-telomerase hypothesis of ageing and cancer. Nature Biotechnol 1996, 14, 836-839.
52. Härle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 1996, 93, 6476-6481.
53. Wright WE, Piatyszek MA, Ramey WE, Byrd W, Shay JW. Telomerase activity in human germline and embryonic tissues and cells. Develop Genet 1996, 18, 173-179.
54. Bunn CL, Tarrant GM. Limited lifespan in somatic cell hybrids and cybrids. Exp Cell Res 1980, 127, 385-396.
55. Pereira-Smith OM, Smith JR. Genetic analysis of indefinite division in human cells: identification of four complementation groups. Proc Natl Acad Sci USA 1988, 85, 6042-6046.
56. Strahl C, Blackburn EH. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Mol Cell Biol 1996, 16, 53-65.
57. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995, 14, 4240-4248.